Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. [electronic resource]
Producer: 20150909Description: 1405-14 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Male
- Middle Aged
- Palliative Care -- methods
- Prognosis
- Regression Analysis
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.